Cargando…

Insight into free energy and dynamic cross-correlations of residue for binding affinity of antibody and receptor binding domain SARS-CoV-2

SARS-CoV-2 virus continues to evolve and mutate causing most of the mutated variants resist to many of the therapeutic monoclonal antibodies (mAbs). Despite several mAbs retained neutralizing capability for Omicron BA.1 and BA.2, reduction in neutralization potency was reported. Hence, effort of sea...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, Wei Lim, Saparpakorn, Patchareenart, Sangma, Chak, Lee, Vannajan Sanghiran, Hannongbua, Supa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809146/
https://www.ncbi.nlm.nih.gov/pubmed/36618128
http://dx.doi.org/10.1016/j.heliyon.2022.e12667
_version_ 1784863064329289728
author Chong, Wei Lim
Saparpakorn, Patchareenart
Sangma, Chak
Lee, Vannajan Sanghiran
Hannongbua, Supa
author_facet Chong, Wei Lim
Saparpakorn, Patchareenart
Sangma, Chak
Lee, Vannajan Sanghiran
Hannongbua, Supa
author_sort Chong, Wei Lim
collection PubMed
description SARS-CoV-2 virus continues to evolve and mutate causing most of the mutated variants resist to many of the therapeutic monoclonal antibodies (mAbs). Despite several mAbs retained neutralizing capability for Omicron BA.1 and BA.2, reduction in neutralization potency was reported. Hence, effort of searching for mAb that is broader in neutralization breadth without losing the neutralizing ability is continued. MW06 was reported with capability in neutralizing most of the variants of concern (VOC) and it binds to the conserved region (left flank) near epitope mAb sotrovimab (S309). In this study, binding affinity of mAb MW06 and its cocktail formulation with MW05 for receptor binding domain (RBD) SARS-CoV-2 virus was investigated under molecular dynamics simulations (MDs). Binding free energies computed by Molecular Mechanics Generalised Born Surface Area (MM-GBSA) algorithm predicted the binding affinity of MW06 for RBD BA.1 (−53 kcal/mol) as strong as RBD wildtype (−58 kcal/mol) while deterioration was observed for RBD BA.2 (−43 kcal/mol). Alike S309 and MW06, simulated cocktail mAb (MW05 and MW06)-RBD interactions suggested the neutralizing capability of the cocktail formulation for RBD BA.1 and BA.2 reduced. Meanwhile, residue pairs that favour the communication between the mAb and RBD have been identified by decomposing the free energy per pairwise residue basis. Apart from understanding the effects of mutation occurred in the RBD region on human angiotensin-converting enzyme 2 (hACE2) binding, impact of heavily mutated RBD on mAb-RBD interactions was investigated in this study as well. In addition to energetic profile obtained from MDs, plotting the dynamics cross-correlation map of the mAb-RBD complex under elastic network model (ENM) was aimed to understand the cross-correlations between residue fluctuations. It allows simple and rapid analysis on the motions or dynamics of the protein residues of mAbs and RBD in complex. Protein residues having correlated motions are normally part of the structural domains of the protein and their respective motions and protein function are related. Motion of mutated RBD residues and mAb residues was less correlated while their respective interactions energy computed to be higher. The combined techniques of MDs and ENM offered simplicity in understanding dynamics and energy contribution that explain binding affinity of mAb-RBD complexes.
format Online
Article
Text
id pubmed-9809146
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98091462023-01-04 Insight into free energy and dynamic cross-correlations of residue for binding affinity of antibody and receptor binding domain SARS-CoV-2 Chong, Wei Lim Saparpakorn, Patchareenart Sangma, Chak Lee, Vannajan Sanghiran Hannongbua, Supa Heliyon Research Article SARS-CoV-2 virus continues to evolve and mutate causing most of the mutated variants resist to many of the therapeutic monoclonal antibodies (mAbs). Despite several mAbs retained neutralizing capability for Omicron BA.1 and BA.2, reduction in neutralization potency was reported. Hence, effort of searching for mAb that is broader in neutralization breadth without losing the neutralizing ability is continued. MW06 was reported with capability in neutralizing most of the variants of concern (VOC) and it binds to the conserved region (left flank) near epitope mAb sotrovimab (S309). In this study, binding affinity of mAb MW06 and its cocktail formulation with MW05 for receptor binding domain (RBD) SARS-CoV-2 virus was investigated under molecular dynamics simulations (MDs). Binding free energies computed by Molecular Mechanics Generalised Born Surface Area (MM-GBSA) algorithm predicted the binding affinity of MW06 for RBD BA.1 (−53 kcal/mol) as strong as RBD wildtype (−58 kcal/mol) while deterioration was observed for RBD BA.2 (−43 kcal/mol). Alike S309 and MW06, simulated cocktail mAb (MW05 and MW06)-RBD interactions suggested the neutralizing capability of the cocktail formulation for RBD BA.1 and BA.2 reduced. Meanwhile, residue pairs that favour the communication between the mAb and RBD have been identified by decomposing the free energy per pairwise residue basis. Apart from understanding the effects of mutation occurred in the RBD region on human angiotensin-converting enzyme 2 (hACE2) binding, impact of heavily mutated RBD on mAb-RBD interactions was investigated in this study as well. In addition to energetic profile obtained from MDs, plotting the dynamics cross-correlation map of the mAb-RBD complex under elastic network model (ENM) was aimed to understand the cross-correlations between residue fluctuations. It allows simple and rapid analysis on the motions or dynamics of the protein residues of mAbs and RBD in complex. Protein residues having correlated motions are normally part of the structural domains of the protein and their respective motions and protein function are related. Motion of mutated RBD residues and mAb residues was less correlated while their respective interactions energy computed to be higher. The combined techniques of MDs and ENM offered simplicity in understanding dynamics and energy contribution that explain binding affinity of mAb-RBD complexes. Elsevier 2023-01-03 /pmc/articles/PMC9809146/ /pubmed/36618128 http://dx.doi.org/10.1016/j.heliyon.2022.e12667 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Chong, Wei Lim
Saparpakorn, Patchareenart
Sangma, Chak
Lee, Vannajan Sanghiran
Hannongbua, Supa
Insight into free energy and dynamic cross-correlations of residue for binding affinity of antibody and receptor binding domain SARS-CoV-2
title Insight into free energy and dynamic cross-correlations of residue for binding affinity of antibody and receptor binding domain SARS-CoV-2
title_full Insight into free energy and dynamic cross-correlations of residue for binding affinity of antibody and receptor binding domain SARS-CoV-2
title_fullStr Insight into free energy and dynamic cross-correlations of residue for binding affinity of antibody and receptor binding domain SARS-CoV-2
title_full_unstemmed Insight into free energy and dynamic cross-correlations of residue for binding affinity of antibody and receptor binding domain SARS-CoV-2
title_short Insight into free energy and dynamic cross-correlations of residue for binding affinity of antibody and receptor binding domain SARS-CoV-2
title_sort insight into free energy and dynamic cross-correlations of residue for binding affinity of antibody and receptor binding domain sars-cov-2
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809146/
https://www.ncbi.nlm.nih.gov/pubmed/36618128
http://dx.doi.org/10.1016/j.heliyon.2022.e12667
work_keys_str_mv AT chongweilim insightintofreeenergyanddynamiccrosscorrelationsofresidueforbindingaffinityofantibodyandreceptorbindingdomainsarscov2
AT saparpakornpatchareenart insightintofreeenergyanddynamiccrosscorrelationsofresidueforbindingaffinityofantibodyandreceptorbindingdomainsarscov2
AT sangmachak insightintofreeenergyanddynamiccrosscorrelationsofresidueforbindingaffinityofantibodyandreceptorbindingdomainsarscov2
AT leevannajansanghiran insightintofreeenergyanddynamiccrosscorrelationsofresidueforbindingaffinityofantibodyandreceptorbindingdomainsarscov2
AT hannongbuasupa insightintofreeenergyanddynamiccrosscorrelationsofresidueforbindingaffinityofantibodyandreceptorbindingdomainsarscov2